#North America MRI

[industryupdate]

The U.S. Led the North America Open MRI System Market

The North America open MRI system market has garnered USD 822.7 million in 2022, and it will touch USD 1,380.8 million, growing at a 6.7% CAGR, by 2030. Learn more about this report: https://bit.ly/44mNI99 The growth of the industry is mainly attributed to the rising incidence of acute and chronic diseases, the cost-efficiency of open MRI systems, and the increasing elderly…

[covid-safer-hotties]

Also preserved in our archive

Another great reason to keep masking: We don't even have a good treatment for long covid yet, and many doctors know simply nothing about the condition.

Global efforts to understand and manage long Covid post-pandemic, with varied symptoms and limited treatment guidelines worldwide

Doctors in India are grappling to diagnose and treat unexplained and persistent symptoms of long Covid patients due to limited guidelines, whereas researchers have flagged inadequate studies on the condition.

With the World Health Organization declaring an end to COVID-19 as a global health emergency in May last year, focused efforts are underway around the world to estimate the burden of long Covid among the population.

The condition refers to the set of lingering symptoms affecting varied body parts and persisting well beyond the acute Covid infection period, including cough, muscle and joint pain, fatigue, brain fog and difficulty in focusing. The viral disease is caused by the SARS-CoV-2 virus.

While studies have suggested that about a third of those moderately or severely infected are likely to suffer from long Covid, region-wise though, incidence could vary.

A study by researchers, including those from Harvard Medical School, U.S., estimated that 31% of the once-infected people in North America, 44% in Europe, and 51% in Asia, have long Covid, which is “challenging the healthcare system, but there are limited guidelines for its treatment”. It was published in the International Journal of Infectious Diseases in September.

In India, however, studies on long Covid are few and far between.

One such study by Maulana Azad Medical College in New Delhi, conducted from May 2022 to March 2023 on 553 patients who had recovered from Covid, found that about 45% had lingering symptoms, persistent fatigue and dry cough being the most common.

“There is limited exploratory research on the long Covid syndrome with scarce data on long-term outcomes,” the authors wrote in the study published in the journal Cureus in May this year.

Understanding the long-term effects of the virus is important for developing management strategies, optimising healthcare delivery, and providing support to recovered Covid patients in the community, they said.

Dr Rajesh Sagar, Professor of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, said, “Looking at the current state of long Covid studies in India, it is too premature to say that we understand the condition well enough to know how to diagnose or treat it.”

Animesh Samanta, assistant professor at School of Natural Sciences in Shiv Nadar University, Greater Noida, said, “While studies in India highlight the growing recognition of neurological complications in long Covid patients, more focused research on neuroinflammation is needed.”

Doctors, too, have reported a rise in patients complaining of symptoms that they did not have pre-Covid. “People who never had asthma in the past, post-Covid, with every viral infection, they get a long cough, shortness of breath and wheezing, which require the use of inhalers or nebuliser,” senior consultant Dr. Neetu Jain, who runs a post-Covid care clinic at Pushpawati Singhania Hospital and Research Institute, New Delhi, said.

Dr. Arun Garg, chairman, Neurology and Neurosciences, Medanta-The Medicity, Gurugram, said that he was noticing a spike in stroke cases among young patients not suffering from known risk factors such as diabetes, hypertension and obesity.

“Similarly, we are seeing more cases of encephalopathy (swelling of the brain) without reason and having a confused state of mind following one or two days of fever. Their MRI scans show no changes. These patients have increased significantly after Covid,” he said.

In the absence of medical guidelines to diagnose long Covid, doctors are having to resort to broad, non-specific tests and questionnaires to gauge a patient’s ‘quality of life’.

Studies have shown that the fatigue experienced in long Covid is similar to that in cancer patients, with a quality of life similar to patients of Parkinson’s disease.

“We really do not have any test to diagnose long Covid, even though it is definitely a clinical diagnosis. We diagnose long Covid for people who had at least moderate to severe infection, following which they could never regain the quality-of-life pre-Covid. Checking for inflammatory markers like C-reactive proteins (CRP) can support the diagnosis,” Dr. Jain said.

“Other than routine blood tests that measure inflammation, we do antibody tests to look for direct markers. In many of these patients, we are finding rare antibodies which are very new to us and were not there pre-Covid,” Dr. Garg said.

Inflammation persisting despite recovery from acute Covid infection is thought to lie at the heart of long Covid. However, tests to measure this specific immune response are lacking, even as researchers have been working in this direction worldwide.

One such effort comes from Shiv Nadar University, where a team led by Mr. Samanta has developed a fluorescent probe capable of detecting inflammation in brain cells that can arise due to Covid infection.

The probe measures nitric oxide levels in brain cells, especially in human microglia cells, where increased NO levels are linked to the SARS-CoV-2 infection. Microglia are immune cells in the brain that fight disease and help maintain brain health.

Lysosomes within microglia, which help clear foreign disease-causing agents like the SARS-CoV-2 virus, produce nitric oxide as part of an immune response to infection. The probe detects nitric oxide produced in lysosomes in response to infection and thereby allows for a measurement of inflammation levels.

This examination method can provide “qualitative information on infection status”, said Mr. Samanta, corresponding author on the study published in the journal Analytical Chemistry in American Chemical Society.

He explained that patients with pre-existing conditions such as Alzheimer’s disease, Parkinson’s disease or multiple sclerosis (an autoimmune disorder) could exhibit prolonged neuroinflammation and loss of brain cells following Covid infection.

While the probe has shown efficacy in cell cultures, animal studies would need to be done, before testing it in humans, Mr. Samanta said.

Looking at the World Health Organization International Clinical Trials Registry Platform, the study by Harvard Medical School had found that 587 clinical studies were conducted on long Covid, of which about 53% (312) were testing potential treatments.

Most of these were found to be conducted in the U.S. (58), followed by India (55) and Spain (20). The trials looked at interventions including physical exercise, psychotherapy, and pharmacological ones such as paxlovid and fluvoxamine.

However, “to date, only 11 of these 312 studies have published their results that were not confirmative,” the researchers wrote.

The team called for studies to look into sleep disorders which were rarely included in the registered clinical studies. Further, interventions targeting the biological processes responsible for long Covid are needed but currently lacking, they said.

[brightlotusmoon]

Study: MRI scans show widespread brain changes in children with ADHD - UPI.com

"...Children with ADHD had abnormal connectivity in the brain networks involved in memory processing and auditory processing, a thinning of the brain cortex, and significant white matter microstructural changes, especially in the frontal lobe of the brain.

The results of the new research on brain biomarkers of ADHD -- based on analysis of data from MRI exams of 7,805 children -- is scheduled to be presented Sunday at the annual meeting of the Radiological Society of North America.

"We found changes in almost all the regions of the brain we investigated," Huang Lin, the study's co-author and a post-graduate researcher at the Yale School of Medicine in New Haven, Conn., said..."

[health-views-updates]

PET Scanners Market Size and Share 2024 | Future Development Analysis and Growth Prospects by 2032

The global PET Scanners Market revenue is on a significant growth trajectory, owing to the increasing prevalence of chronic diseases, technological advancements, and a higher demand for non-invasive diagnostic tools. Positron Emission Tomography (PET) scanners have emerged as essential devices in modern healthcare, providing high-precision imaging that enables accurate diagnosis and treatment planning, particularly in fields such as oncology, cardiology, and neurology. The market’s expansion reflects the escalating need for early detection and personalized treatment approaches, which are key drivers in improving patient outcomes.

PET scanners utilize radioactive tracers and specialized imaging techniques to detect abnormal metabolic processes within the body. As the technology continues to evolve, with innovations like hybrid PET/CT and PET/MRI systems, the accuracy and detail provided by these devices have markedly improved. These advancements not only facilitate early disease detection but also empower clinicians with more comprehensive data for targeted treatments. The adoption of such cutting-edge diagnostic tools is further reinforced by favorable government initiatives, increasing investments in healthcare infrastructure, and heightened awareness of the benefits of early diagnosis.

Market dynamics indicate a positive outlook, with the PET scanners sector witnessing substantial interest across North America, Europe, Asia-Pacific, and other regions. Developed countries with established healthcare systems have been early adopters of advanced PET technology, while emerging markets show strong potential for growth due to rising healthcare expenditures and increasing awareness of medical imaging advancements. The expansion of the PET scanners market is also supported by ongoing research and development activities aimed at enhancing the functionality, accuracy, and accessibility of PET scanners to better meet clinical needs.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/4152

Growing Demand for Hybrid Imaging Systems and Portable PET Scanners Fuels Market Expansion

One of the most significant trends within the PET scanners market is the rise in demand for hybrid imaging systems. PET/CT and PET/MRI scanners, which combine PET technology with computed tomography (CT) or magnetic resonance imaging (MRI), offer comprehensive imaging solutions by providing anatomical and functional details in a single scan. Such hybrid systems have gained widespread acceptance among healthcare providers for their accuracy in detecting and staging various cancers, heart conditions, and neurological disorders. The integration of multiple imaging modalities not only improves diagnostic accuracy but also optimizes patient management, reducing the need for additional tests and thereby lowering overall healthcare costs.

Portable and compact PET scanners have also gained traction in recent years, particularly in settings where traditional, large-scale scanners may not be feasible. These portable devices are increasingly utilized in outpatient clinics, rural healthcare facilities, and in-home care environments, making PET scanning more accessible to a broader patient population. As healthcare providers and institutions continue to emphasize patient-centric care, the demand for portable PET scanners is expected to rise, further propelling the market forward.

Emerging Applications of PET Scanners in Neurology and Cardiology Open New Growth Opportunities

While PET scanners are primarily used in oncology for the diagnosis and staging of cancer, their applications are rapidly expanding into neurology and cardiology. In neurology, PET imaging is used to study brain activity, identify neurological conditions like Alzheimer’s disease, and assess other cognitive disorders. Similarly, in cardiology, PET scanners play a crucial role in evaluating heart health, detecting myocardial viability, and planning interventions. These emerging applications open new growth opportunities for the PET scanners market, as more healthcare providers recognize the value of PET imaging in the early diagnosis and personalized treatment of complex diseases.

With continuous advancements in imaging technology, PET scanners are expected to become more sophisticated and precise. Artificial intelligence (AI) and machine learning are set to play an integral role in enhancing the capabilities of PET scanners, enabling quicker data analysis and better image resolution. These technological improvements not only make PET scanners more efficient but also enable faster, more accurate diagnoses, ultimately leading to improved patient outcomes. As AI integration progresses, healthcare providers are likely to experience a significant reduction in diagnostic times, further optimizing the workflow in radiology departments.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[molsons112000]

Scientists Found a 'Yellow Brick Road' at The Bottom of The Pacific Ocean : ScienceAlert

We're gonna find more and more of this cool stuff, but they need to be able to take biopsies of the seabed.... yes the samples...

They can use all kinds of imaging systems as well... so all the imaging systems from MRI to CT scans to ultrasounds, and sonograms, can all be used in deep sea expiration and mining industries... They can also be used in construction industries as well, obviously archaeology...

ResearchGate

https://www.researchgate.net › 266...

(PDF) The Emergence of Magnetic Resonance Imaging (MRI) for 3D ...

Magnetic Resonance Imaging (MRI) can be used for 3D analysis of small-scale porous media structure and internal flow-related processes

So again, we need these systems also for space to be able to analyze planets more deeply... So all these medical systems have utilizations in many other industries, like deep sea analysis and space analysis....

These systems can be used in analyzing caves, either in the deep sea or under lakes, a rivers and as well as a land...

Nature

https://www.nature.com › articles

Measurement and modelling of deep sea sediment plumes and ...

by J Spearman · 2020 · Cited by 93 — We present the results of novel in situ deep sea plume experiments undertaken on the Tropic seamount, 300 nautical miles SSW of the Canary Islands.



ScienceDirect.com

https://www.sciencedirect.com › pii

Monitoring of a sediment plume produced by a deep-sea mining ...

by S Haalboom · 2023 · Cited by 18 — In this study different experimental designs for monitoring of sediment plumes produced by deep-sea mining are presented.



Geological Society of America

https://www.geosociety.org › ...PDF

Imaging Laurentide Ice Sheet Drainage into the Deep Sea



To do this, state-of-the-art sidescan-sonar imagery and swath bathymetry were acquired using the. HAWAII MR-1 (Hawaii Institute of Geo- physics Acoustic Wide- ...

7 pages·408 KB



ScienceDirect.com

https://www.sciencedirect.com › pii

Experimental investigation of the inhibition of deep-sea mining ...

by F Zhang · 2024 · Cited by 1 — The sediment used in the experiment was collected from the deep seabed during the 66th voyage of China

[farmacuticals]

Technological Advancements Driving the Contrast Injector Market: An Industry Overview

Contrast injectors are medical devices used in diagnostic imaging procedures to introduce contrast media into a patient's body, enhancing the visibility of tissues, organs, and blood vessels. They are commonly employed in radiology procedures like CT scans, MRIs, and angiography, where accurate imaging is essential for diagnosis. Contrast injectors allow precise control over the injection rate and volume, ensuring consistent delivery of the contrast agent. With advanced technology, these devices help healthcare professionals achieve better diagnostic quality while ensuring patient safety, reducing errors, and enabling detailed visualization of internal structures.

In 2022, the market for contrast injectors was projected to be worth 13.07 billion USD. By 2032, the contrast injector market is projected to have grown from 13.71 billion USD in 2023 to 21.2 billion USD. Over the course of the forecast period (2024–2032), the contrast injector market is anticipated to develop at a CAGR of approximately 4.96%.

Size Contrast Injector Share

The global market for contrast injectors has seen significant growth over the years, driven by an increase in diagnostic imaging procedures worldwide. Factors such as the rising prevalence of chronic diseases, technological advancements, and an aging population are contributing to the increased adoption of contrast injectors. The size Contrast Injector share within the healthcare imaging market continues to expand as hospitals, diagnostic centers, and research facilities invest in advanced imaging technology. North America, Europe, and Asia-Pacific are leading regions in terms of market share, with North America holding the largest due to its developed healthcare infrastructure and high diagnostic procedure rates.

Contrast Injector Analysis

The contrast injector market is witnessing a dynamic transformation as manufacturers develop advanced devices with user-friendly features, such as automated contrast delivery systems and integration with imaging modalities. In addition to increased safety features, there is a rising demand for injectors with better data management and software compatibility. Contrast Injector Analysis indicates that this market's growth is further fueled by increased healthcare spending, supportive government initiatives, and advancements in healthcare IT systems. However, high costs associated with contrast injectors and regulatory compliance challenges may pose barriers to market growth.

Contrast Injector Trends

Several trends are shaping the future of the contrast injector market. First, the demand for dual-head injectors, which allow for simultaneous injection of saline and contrast media, is rising due to enhanced imaging capabilities. Second, portable and wireless contrast injectors are becoming popular in remote and emergency healthcare settings. Third, the integration of contrast injectors with hospital information systems and electronic health records enables better data tracking and patient monitoring. Fourth, eco-friendly contrast injectors that minimize waste and use lower volumes of contrast agents are gaining traction. Finally, artificial intelligence and machine learning are beginning to play a role in optimizing contrast injection protocols, personalizing patient care, and reducing potential side effects.

Reasons to Buy the Reports

In-depth Market Analysis: Obtain a comprehensive analysis of the global contrast injector market, including key drivers, challenges, and emerging trends.

Competitive Landscape Insight: Understand the competitive landscape and strategies adopted by major players, including product launches, partnerships, and acquisitions.

Market Size & Forecasting: Access accurate data on market size Contrast Injector share, growth projections, and potential opportunities in key regions.

Technological Advancements: Gain insights into the latest technological developments, such as AI integration, wireless systems, and dual-head injectors.

Regulatory Impact: Understand the regulatory requirements and compliance standards impacting the contrast injector market, aiding in strategic decision-making.

Recent Developments

Recent developments in the contrast injector market highlight advancements in device technology and strategic partnerships. For instance, several companies have introduced AI-enabled contrast injectors that personalize dosage based on patient-specific factors, aiming to enhance safety and diagnostic accuracy. Additionally, partnerships between contrast media suppliers and injector manufacturers have resulted in streamlined solutions for radiology departments. Wireless and portable contrast injectors are also seeing increased demand, especially in emergency medical care. Furthermore, market players are exploring eco-friendly materials and designs to reduce the environmental impact, aligning with the healthcare industry’s shift toward sustainable practices.

The contrast injector market is well-positioned for growth as innovations continue to improve patient outcomes and streamline diagnostic procedures.

Related reports:

healthcare informatics market

healthcare payer network management market

image guided surgery market

Top of Form

Bottom of Form

[sapana22]

Medical Imaging Phantoms Share | Segmented by Top Manufacturers & Geography Regions

Medical Imaging Phantoms Market: Strategic Insights, Key Players, and Forecasts by 2031

The latest Medical Imaging Phantoms Market Report provides a comprehensive analysis of growth projections, strategic insights, and competitive landscape. As the market recovers post-pandemic, significant growth is anticipated. This report delivers valuable information for business strategists, combining an overview of industry standards, strategic trends, and emerging patterns among key players. It serves as an essential resource for market stakeholders planning future steps in the industry.

This research document includes detailed industry overviews, growth analysis, and historical and projected data on costs, revenue, supply, and demand. Market analysts provide an in-depth analysis of the value chain and distribution networks. Analytical tools like SWOT analysis, Porter’s Five Forces, and feasibility studies are applied to assess competitive dynamics, entry barriers, and opportunities, giving stakeholders strategic insights into current and future trends.

According to Straits Research, the global Medical Imaging Phantoms Market size was valued at USD 157.08 Million  in 2022. It is projected to grow from USD XX Million  in 2023 to USD 231.03 Million by 2031, with a projected CAGR of 4.38% over the forecast period (2023–2031).

Request a Free Sample (Free Executive Summary at Full Report Starting from USD 1850): https://straitsresearch.com/report/medical-imaging-phantoms-market/request-sample

Key Report Highlights

Market Overview and Competitive Landscape: Covers strategic insights on key players, their market share, recent advancements, and effective marketing tactics.

Segmentation Analysis: Divides the market into sub-segments based on product type, application, and regions, with both macro and micro-level analysis.

Regional Insights: Offers revenue forecasts and trend analysis across major geographies, including:

North America: United States, Canada, Mexico

Europe: United Kingdom, France, Germany, Russia

Asia-Pacific: China, Japan, Australia, Indonesia

Middle East & Africa: UAE, Iran, South Africa

South America: Brazil, Peru, Chile, Colombia

Emerging Trends and Opportunities: Highlights growth drivers, constraints, market trends, and high-growth areas, assisting companies in identifying future business opportunities.

Buy Full Report (Exclusive Insights with In-Depth Data Supplement) :https://straitsresearch.com/buy-now/medical-imaging-phantoms-market

Top Players in the Medical Imaging Phantoms Market

The report highlights leading companies, including 

Biodex Medical Systems, Inc.

Pure Imaging Phantoms

Modus Medical Devices Inc.

Gold Standard Phantoms

True Phantom Solutions

Carville Limited

Computerized Imaging Reference Systems, Inc.

PTW Freiburg GmbH

Quart GmbH

Leeds Test Objects Ltd

Dielectric Corporation

PhantomX

Kyoto Kagaku Co. Ltd

Medical Imaging Phantoms Market Segmental Analysis

By Device Type

X-ray

Ultrasound

CT

MRI

Nuclear imaging

Others

By Material

Stimulating Devices

False Organ

By End-User

Hospitals

Diagnostic Laboratories

Others

Market Segmentation with Insights-Driven Strategy Guide: https://straitsresearch.com/report/medical-imaging-phantoms-market/segmentation

Reasons to Purchase This Report

Gain insights into the evolving competitive landscape and top players’ growth strategies.

Access strategic planning tools to support informed business decisions.

Benefit from regional market estimates and detailed profiles of stakeholders.

Understand critical market segments and identify trending factors impacting growth.

Research Methodology

Straits Research utilizes a robust methodology involving data triangulation with top-down and bottom-up approaches. Market estimates are validated through primary research and stakeholder interviews. Reliable sources are used to determine market size and forecasts across segments globally, regionally, and nationally.

Table of Contents for the Medical Imaging Phantoms Market Report: https://straitsresearch.com/report/medical-imaging-phantoms-market/toc

About Straits Research

Straits Research is a leading provider of market research and intelligence services. With a focus on high-quality research, analytics, and advisory, our team offers actionable insights tailored to clients’ strategic needs.

Contact Us Email: sales@straitsresearch.com Address: 825 3rd Avenue, New York, NY, USA, 10022 Tel: UK: +44 203 695 0070, USA: +1 646 905 0080

[shubhampawrainfinium]

Precision Healing: Unraveling the Power of Tissue Ablation

The global tissue ablation market is experiencing notable growth due to increasing demand for minimally invasive procedures, advancements in ablation technologies, and a rise in chronic disease incidences. According to the report, the market is projected to expand at a compound annual growth rate (CAGR) of nearly 8% over the forecast period from 2022 to 2028. Valued at over USD 1,200 million in 2022, it is expected to reach approximately USD 2,000 million by 2028.

What is Tissue Ablation?

Tissue ablation refers to the medical procedure that uses thermal, chemical, or other energy sources to destroy or remove abnormal tissue, primarily used in treating cancer, cardiovascular diseases, and chronic pain. Ablation techniques include radiofrequency (RF) ablation, microwave ablation, cryoablation, laser ablation, and others, each catering to specific medical needs with minimal invasiveness.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/41143

Market Dynamics and Growth Drivers

Several factors drive the global tissue ablation market:

Rising Incidences of Chronic Diseases: The global rise in chronic conditions, such as cancer, cardiovascular disease, and liver disorders, has driven demand for ablation procedures. Ablation techniques are increasingly used for tumor removal and managing arrhythmias and other conditions.

Shift Toward Minimally Invasive Procedures: Patients and healthcare providers are increasingly opting for minimally invasive treatments that offer quicker recovery times, reduced hospital stays, and lower risk of complications. Ablation techniques fulfill these preferences, thus boosting their adoption in various clinical settings.

Technological Advancements in Ablation Devices: Advancements in ablation devices, including improvements in imaging technologies, robotics, and precision targeting, have enhanced procedure effectiveness and safety. For example, the integration of MRI and ultrasound with ablation technologies provides real-time monitoring, allowing for precise treatment.

Increasing Geriatric Population: As the elderly population grows, there is a corresponding increase in age-related health issues that require ablation, such as cardiovascular arrhythmias and prostate conditions. The elderly are particularly inclined toward minimally invasive solutions, which support market growth.

Regional Analysis

North America: North America leads the tissue ablation market, attributed to a high prevalence of chronic diseases, advanced healthcare infrastructure, and substantial investment in healthcare research. The United States, in particular, shows high demand for ablation therapies for cancer and cardiovascular conditions.

Europe: The European market benefits from increased government funding for healthcare research and growing awareness of minimally invasive procedures. Leading countries such as Germany, France, and the U.K. show substantial market activity in tissue ablation technologies.

Asia-Pacific: The Asia-Pacific region is anticipated to show the fastest growth, driven by factors such as a large population base, rising healthcare expenditure, and growing incidences of chronic diseases. Countries like China, Japan, and India are investing heavily in healthcare advancements, supporting the growth of ablation procedures.

Latin America, Middle East, and Africa: These regions are gradually adopting tissue ablation technologies, supported by improving healthcare infrastructure and rising medical tourism. While growth rates are more modest, awareness and accessibility to advanced healthcare are gradually increasing.

Competitive Landscape

The tissue ablation market is highly competitive, with key players focusing on innovations, strategic collaborations, and expanding their product portfolios. Prominent companies include:

Medtronic: A leader in medical device innovation, Medtronic offers a range of ablation solutions across cardiovascular, oncology, and pain management applications. The company focuses on expanding its minimally invasive product lines and enhancing product precision.

Boston Scientific Corporation: Boston Scientific specializes in ablation products for oncology and cardiology, with an emphasis on RF ablation and cryoablation technologies. The company’s focus on R&D and new product launches helps maintain its competitive edge.

Johnson & Johnson (Ethicon): Known for its advanced ablation systems, Johnson & Johnson’s Ethicon division has a strong market presence, particularly in cancer and pain management. The company invests in robotics and AI-based imaging technologies to improve procedural outcomes.

Abbott Laboratories: Abbott provides a range of devices for electrophysiology and ablation, especially for treating atrial fibrillation. Abbott’s innovative solutions aim to improve procedural accuracy and minimize patient discomfort.

AngioDynamics: Focused on oncology and vascular applications, AngioDynamics offers microwave ablation systems for precise tumor ablation. The company emphasizes product affordability and ease of use, making it a preferred choice in cost-sensitive markets.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-tissue-ablation-market

Challenges and Opportunities

Despite the growth prospects, the tissue ablation market faces certain challenges, such as the high cost of ablation procedures and equipment, limited access in low-resource settings, and risks associated with complications like infection or damage to surrounding tissues. Additionally, regulatory hurdles in introducing new technologies can slow down product launches.

However, there are considerable opportunities in the market, including the development of next-generation ablation devices that leverage artificial intelligence and robotics for enhanced precision. Increasing investments in healthcare infrastructure in emerging economies also create a favorable environment for expanding ablation technology applications.

Conclusion

The global tissue ablation market is poised for significant growth, with projections showing a rise from USD 1,200 million in 2022 to nearly USD 2,000 million by 2028, at a CAGR of almost 8%. Demand for minimally invasive, precision-based procedures and technological innovations are driving this growth. As companies continue to expand their product offerings and penetrate emerging markets, the adoption of tissue ablation techniques will further accelerate, addressing an ever-growing need for effective and less invasive treatment options worldwide.

Discover More of Our Reports

Heparin Market

Portable Power Station Market

[businessmarketreports]

An Overview of North America Patient Examination Devices Market: Trends and Insights

The North American patient examination devices market is a dynamic and rapidly evolving sector, driven by increasing healthcare expenditure, technological advancements, and a growing aging population.

Key Trends Shaping the Market:

Technological Advancements:

Digital Imaging: The increasing adoption of digital imaging technologies, such as digital X-ray and ultrasound, is improving diagnostic accuracy and efficiency.

Telehealth and Remote Monitoring: The integration of telehealth and remote monitoring technologies is enabling remote patient assessment and diagnosis.

AI and Machine Learning: The application of AI and machine learning algorithms is enhancing the accuracy and speed of medical diagnosis.

Aging Population: The aging population in North America is associated with a higher prevalence of chronic diseases, leading to increased demand for patient examination devices.

Rising Healthcare Expenditure: Increased healthcare spending is enabling greater access to advanced medical devices and technologies.

Focus on Patient-Centered Care: The emphasis on patient-centered care is driving the development of patient-friendly and user-friendly examination devices.

Major Product Segments:

Diagnostic Imaging Equipment: Includes X-ray machines, ultrasound systems, CT scanners, and MRI machines.

Ophthalmic Devices: Used for eye examinations, including ophthalmoscopes and slit lamps.

Otoscopes: Used for ear examinations.

Vital Signs Monitoring Devices: Used to measure blood pressure, heart rate, and other vital signs.

Challenges and Opportunities:

Regulatory Hurdles: Navigating the complex regulatory landscape for medical devices in North America can be challenging.

Reimbursement Challenges: Obtaining adequate reimbursement for advanced medical devices can be difficult, particularly in a cost-conscious healthcare environment.

Supply Chain Disruptions: Global supply chain disruptions can impact the availability and cost of medical devices.

Emerging Technologies: The development of innovative medical devices, such as wearable health monitors and point-of-care diagnostic devices, presents significant opportunities for the market.

Conclusion

The North American patient examination devices market is a dynamic and growing sector. By addressing challenges such as regulatory hurdles, reimbursement issues, and supply chain disruptions, the market can continue to expand and improve patient care.

[deshpandeisha]

Introduction to Transradial Access: Advantages and Clinical Applications

The global transradial access market size was USD 2.00 Billion in 2022 and is expected to register a revenue CAGR of 7.4% during the forecast period. Transradial Access (TRA) is the recommended method for coronary angiography and Percutaneous Coronary Intervention (PCI) as it has a lower risk of bleeding and vascular problems than Transfemoral Access (TFA), increases patient satisfaction, and lowers patient mortality.

The increasing prevalence of coronary artery diseases and cardiovascular diseases, growing prevalence of obesity, and rising adoption of interventional procedures are some of the key factors driving the market revenue growth. In addition, increasing product launches and initiations by leading companies and rising prevalence of lifestyle diseases are contributing significantly to revenue growth of the market.

However, there are some restraints for revenue growth of the global Transradial Access Market. High cost of Transradial Access and product recalls are restraining the market revenue growth. The expertise required by the technique, the growing trend of a product recall, and the risk of failure are the major challenges to the growth of the market. The lack of healthcare facilities in underdeveloped regions has created an opportunity for key players to enter the untapped market.

The North America market accounted for the largest revenue share than other regional markets in the global transradial access market in 2022. The region has established itself as the market leader with a significant market share. A large number of individuals in the region suffer from obesity and diabetes. Because of the obesity epidemic in the United States, a growing proportion of patients have panniculus, which impedes TFA access. Obesity requires inventive patient placement to expose the femoral crease, mandates interventionalist access to atypically deep femoral arteries, and raises the risk of post-procedure bleeding and access site infection. Given that the wrist has less fat than the femoral artery accessing the radial artery in obese individuals overcomes several difficulties. Increasing healthcare expenditures and rising alcohol and cigarette consumption in the region also contribute to the expansion of the industry.

On the basis of end-use, the global transradial access market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment accounted for the largest revenue in 2022 owing to the high prevalence of highly qualified healthcare professionals, and staff as well as the high percentage of diagnostics tests performed in hospitals and clinics, which is driving the segment revenue growth. Availability of long-term care facilities, as well as continuous patient monitoring, are two major factors driving revenue growth of this segment. The hospitals segment provides several diagnostics tests such as blood tests, Computed Tomography (CT) scans, capsule endoscopy, Magnetic Resonance Imaging (MRI), ultrasound, and other imaging services. As a result, it contributes significantly to revenue growth of this segment.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1960

Competitive Terrain:

The global Transradial Access industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Terumo Corporation, Medtronic, Edwards Lifesciences Corporation., Nipro Medical Corporation, Boston Scientific Corporation, AngioDynamics., Teleflex Incorporated., Penumbra, Inc., Hollister Incorporated, Abbott

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Transradial Access market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Transradial Access market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Transradial Access market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1960

Market Segmentations of the Transradial Access Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Transradial Access market on the basis of product, application, and region:

Segments Covered in this report are:

Product Outlook (Revenue, USD Billion; 2019-2032)

Catheters

Guidewires

Sheaths & Sheath Introducers

Accessories

Application Outlook (Revenue, USD Billion; 2019-2032)

Fluid and nutrition administration

Drug administration

Blood transfusion

Diagnostics and testing

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals and clinics

Ambulatory surgical centers

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/transradial-access-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1960

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market

[harshnews]

Menstrual Cramps Treatment Market Size, Share, Trends, Growth and Competitive Analysis

"Global Menstrual Cramps Treatment Market – Industry Trends and Forecast to 2030

Global Menstrual Cramps Treatment Market, By Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment Type (Medication, Therapy, Surgery, Others), Diagnosis (Ultrasound, Laparoscopy, CT scan, magnetic resonance imaging (MRI), Others), Mode of Prescription (Over the Counter, Prescription), Route of Administration (Oral, Parenteral, Implants, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.

Access Full 350 Pages PDF Report @

**Segments**

- **Treatment Type** - Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - Hormonal Contraceptives - Alternative Therapies

- **Distribution Channel** - Retail Pharmacies - Online Pharmacies - Others

- **Region** - North America - Europe - Asia-Pacific - Latin America - Middle East and Africa

The menstrual cramps treatment market can be segmented based on treatment type, distribution channel, and region. In terms of treatment type, the market is divided into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Hormonal Contraceptives, and Alternative Therapies. NSAIDs are commonly used to relieve menstrual cramp pain by reducing inflammation. Hormonal contraceptives like birth control pills can help regulate menstrual cycles and alleviate cramps. Alternative therapies such as acupuncture, yoga, and herbal remedies are also increasingly being sought after for managing menstrual cramps. Regarding distribution channels, the market is categorized into retail pharmacies, online pharmacies, and others. Retail pharmacies remain a crucial channel for consumers to access over-the-counter and prescription menstrual cramp treatments, while the online pharmacies segment is witnessing significant growth due to the convenience and privacy they offer to consumers. Geographically, the market is analyzed across regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, each presenting unique market dynamics and opportunities for menstrual cramps treatment products.

**Market Players**

- **Pfizer Inc.** - **Bayer AG** - **Sanofi** - **Johnson & Johnson Services, Inc.** - **Merck & Co., Inc.** - **Novartis AG** - **Abbott** - **Reckitt Benckiser Group plc** - **GlaxoSmithKline plc** - **Mylan N.V.**

Key players in the menstrual cramps treatment market include pharmaceutical giants such asThe menstrual cramps treatment market is highly competitive with several key players dominating the industry. Pfizer Inc., known for its wide range of pharmaceutical products, offers NSAIDs and hormonal contraceptives targeting menstrual cramp relief. Bayer AG is another major player in the market with a focus on women's health, providing hormonal contraceptives and alternative therapies for menstrual cramp management. Sanofi, a global pharmaceutical company, also has a presence in the market with its diverse portfolio of treatment options for menstrual cramps. Johnson & Johnson Services, Inc., a well-known healthcare company, offers over-the-counter medications and medical devices for menstrual cramp relief. Merck & Co., Inc. is another significant player in the market, known for its research and development in women's health therapeutics.

Novartis AG, a Swiss multinational pharmaceutical company, has a presence in the menstrual cramps treatment market with its innovative products and research initiatives. Abbott, a global healthcare company, also participates in the market with its range of pharmaceuticals and healthcare products aimed at women's health. Reckitt Benckiser Group plc, a British multinational consumer goods company, offers over-the-counter remedies and alternative therapies for menstrual cramp management. GlaxoSmithKline plc, a leading healthcare company, provides a variety of pharmaceutical products targeting menstrual cramps. Mylan N.V., a global pharmaceutical company, also competes in the market with its portfolio of affordable generic medications for menstrual cramp treatment.

These key players in the menstrual cramps treatment market are constantly innovating and investing in research and development to introduce new and improved treatment options for consumers. They also focus on strategic partnerships and acquisitions to expand their market presence and reach a wider consumer base. Market players are increasingly focusing on product differentiation, pricing strategies, and marketing initiatives to stand out in the competitive landscape and capture a larger share of the market.

Factors such as increasing awareness about menstrual health, growing prevalence of menstrual disorders, and rising demand for alternative therapies are driving the**Segments**

- **Global Menstrual Cramps Treatment Market, By Type** - Primary Dysmenorrhea - Secondary Dysmenorrhea

- **Treatment Type** - Medication - Therapy - Surgery - Others

- **Diagnosis** - Ultrasound - Laparoscopy - CT scan - Magnetic Resonance Imaging (MRI) - Others

- **Mode of Prescription** - Over the Counter - Prescription

- **Route of Administration** - Oral - Parenteral - Implants - Others

- **End-Users** - Hospitals - Specialty Clinics - Homecare - Others

- **Distribution Channel** - Hospital Pharmacy - Retail Pharmacy - Online Pharmacy - Others

The global menstrual cramps treatment market exhibits various segments crucial for understanding the market landscape and catering to the diverse needs of consumers seeking relief from menstrual cramps. The differentiation between primary and secondary dysmenorrhea helps in tailoring treatments specific to the underlying causes of menstrual pain. Treatment types such as medication, therapy, surgery, and alternative therapies offer a spectrum of options for managing menstrual cramps effectively. Diagnostics tools like ultrasound, laparoscopy, CT scans, and MRI play a pivotal role in identifying underlying conditions contributing to menstrual pain, enabling healthcare providers to suggest targeted treatment approaches. The mode

TABLE OF CONTENTS

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers and Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Core Objective of Menstrual Cramps Treatment Market:

Every firm in the Menstrual Cramps Treatment Market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.

Size of the Menstrual Cramps Treatment Market and growth rate factors.

Important changes in the future Menstrual Cramps Treatment Market.

Top worldwide competitors of the Market.

Scope and product outlook of Menstrual Cramps Treatment Market.

Developing regions with potential growth in the future.

Tough Challenges and risk faced in Market.

Global Menstrual Cramps Treatment top manufacturers profile and sales statistics.

Browse Trending Reports:

Meat Poultry And Seafood Processing Equipment Market Hemiballismus Treatment Market Fluid And Lubricant Market Virtual Infrastructure Manager Market Water Flosser Market Water Saving Shower Heads Market Galactoligosaccharides Market Rocky Mountain Spotted Fever Treatment Market Overhead Conveyor Market Olliers Disease Market Functional Bowel Disorder Agents Market Bio Based Leather Market Melanoma Cancer Diagnostics Market Intracranial Hematoma Drug Market Glucosinolates Market Autorefractor Keratometer Device Market Feed Mycotoxin Modifiers Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[dh5ryxhgbctgr]

Cryocooler Market Insights and Future Growth Estimates 2024 - 2032

The cryocooler market plays a crucial role in various high-tech applications, providing essential cooling solutions for a range of industries, including aerospace, medical, and electronics. This article explores the current state of the cryocooler market, its drivers, challenges, and future trends.

Introduction to Cryocoolers

Cryocoolers are refrigeration devices designed to reach and maintain cryogenic temperatures, typically below -150°C. They are used to cool materials and systems in applications that require low temperatures, such as superconducting materials, infrared sensors, and cryopreservation of biological samples.

How Cryocoolers Work

Cryocoolers operate on various thermodynamic cycles, including the Stirling, Gifford-McMahon, and pulse tube cycles. Each type has unique characteristics that make it suitable for different applications, but all are designed to extract heat from a system and transfer it away, achieving low temperatures.

Market Overview

Current Market Size and Growth

The global cryocooler market has witnessed substantial growth, driven by advancements in technology and increased demand for cooling solutions in sectors like aerospace, healthcare, and energy. Factors such as research and development in cryogenics and the need for efficient cooling systems are propelling market expansion.

Key Segments of the Market

By Type

Stirling Cryocoolers: Known for their high efficiency and reliability, commonly used in space applications and scientific research.

Gifford-McMahon Cryocoolers: Frequently used in military and commercial applications, offering a balance between performance and cost.

Pulse Tube Cryocoolers: Gaining popularity due to their low vibration and maintenance-free operation, ideal for sensitive applications.

By Application

Aerospace: Essential for cooling sensors and instruments in satellites and aircraft.

Medical: Used in MRI machines and cryopreservation systems for biological samples.

Electronics: Critical for cooling superconducting components in advanced computing systems.

By Geography

North America: Leading region, driven by significant investments in aerospace and defense sectors.

Europe: Focused on research and development in cryogenics and growing demand in medical applications.

Asia-Pacific: Fastest-growing market, supported by increasing industrialization and advancements in technology.

Market Drivers

Advancements in Cryogenic Technology

Innovations in cryogenic technology are enhancing the efficiency and performance of cryocoolers. Improved designs and materials are enabling more compact and lightweight systems, which are crucial for applications in aerospace and portable medical devices.

Growing Demand in Healthcare

The medical sector's increasing reliance on cryogenic systems for diagnostics, treatment, and preservation of biological materials is a significant driver of the cryocooler market. Technologies such as MRI machines and cryopreservation techniques require efficient cooling solutions.

Expansion of Aerospace and Defense Applications

The aerospace industry’s ongoing demand for advanced cooling systems for satellites, space probes, and military applications is propelling market growth. Cryocoolers play a vital role in ensuring the reliability and performance of these systems.

Challenges Facing the Market

High Initial Costs

The initial investment for cryogenic systems can be substantial, which may deter some potential customers. The high costs associated with manufacturing and maintaining cryocoolers can limit their adoption in cost-sensitive markets.

Limited Awareness and Understanding

The complexity of cryogenic systems may result in limited awareness among potential users. Educating stakeholders about the benefits and applications of cryocoolers is essential for market growth.

Technological Limitations

While advancements are being made, certain technological limitations still exist. Achieving ultra-low temperatures efficiently and maintaining performance over extended periods can pose challenges.

Future Outlook

Increasing Research and Development

The cryocooler market is expected to benefit from increased investment in research and development. Innovations in materials, designs, and technologies will continue to enhance the performance and efficiency of cryocoolers.

Expansion into Emerging Markets

As industries in developing regions expand, the demand for advanced cooling solutions is expected to rise. Emerging markets in Asia-Pacific and Latin America present significant opportunities for growth in the cryocooler market.

Integration with Renewable Energy

The integration of cryocoolers in renewable energy applications, such as energy storage systems and efficient cooling for power generation, will drive further growth. As the focus on sustainable solutions increases, cryogenic technology can play a vital role.

Conclusion

The cryocooler market is poised for significant growth as advancements in technology and increasing demand across various sectors drive innovation. While challenges remain, the opportunities for cryocoolers in aerospace, healthcare, and emerging markets present a bright future. Stakeholders must navigate this evolving landscape to leverage the benefits of cryogenic technology and meet the growing demand for efficient cooling solutions

More Trending Reports

Industrial Air Compressor Market

Digital Oilfield Market

Solar Water Pumps Market

Wind Tower Market

[industrynewsupdates]

Medical Plastics Market Key Companies and Emerging Trends 2024 - 2030

The global medical plastics market size was estimated at USD 52.9 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2030.

This growth can be attributed to the development of advanced plastics and plastic composites used in medical components such as catheters, surgical instrument handles, and syringes. The demand for medical device packaging is likely to be driven by a rise in demand for in-house and advanced medical devices. Plastics including polyethylene, polypropylene, and polycarbonate are increasingly being utilized for the manufacturing of medical devices. The growth of home healthcare due to its low costs compared to hospital care and intensive care has resulted in a rise in demand for medical devices.

According to the latest U.S. census, 16.8% of the U.S. population is over the age of 65 years and this number is anticipated to reach 74 million by 2030. People aged over 85 need the most care and their population is growing rapidly. In March 2021, the U.S. President, Joe Biden, proposed spending USD 400 billion on Medicaid over eight years to fund at-home care for elderly and disabled people as well as increase the wages of caregivers.

Gather more insights about the market drivers, restrains and growth of the Medical Plastics Market

Detailed Segmentation:

Market Concentration & Characteristics

Market growth stage is high, and pace of market growth is accelerating owing to overly consolidated market. Medical plastic manufacturers are actively implementing challenging strategic initiatives such as mergers & acquisitions, new product launches, production expansion, among others.

For instance, In November 2023, TekniPlex Healthcare announced the acquisition of Seisa Medical, a medical device manufacturer based in El Paso, Texas, offering various services throughout the product development cycle. This acquisition will enhance the company's materials science and process technologies worldwide for interventional therapy devices and minimally invasive. From development and design to component manufacturing, final assembly, and packaging, Seisa provides global contract manufacturing services for Class II and III medical devices and specialty components.

Process Technology Insights

Injection molding is a widely used process in the medical plastics industry. It has many advantages, including compliance with medical industry standards and regulations. The use of engineering-grade plastics ensures that parts are created to enhance patient safety and comply with FDA (Food and Drug Administration) guidelines. Injection molding is highly flexible, allowing parts to be fully customizable to fit the consumer.

Application Insights

The medical components segment dominated with a revenue share above 40.0% in 2023. The COVID-19 pandemic increased the demand for medical components such as personal protective equipment (PPE), face masks, gloves & gowns, and magnetic resonance imaging (MRI) scanners. The emerging countries manufactured PPE, face masks, and gloves, whereas, developed countries manufactured technology-intensive equipment such as MRI scanners and mechanical ventilators. Hence, the demand for the aforementioned equipment was rising during the pandemic, which in turn is expected to drive the segment’s growth.

Regional Insights

In 2023, North America dominated global medical plastics market with a market share of above 33.0%. This is expected to augment the demand for generic drugs as well as medical devices in the coming years, thereby driving North America medical plastics market over the forecast period. The key applications catered to by this industry include pharmaceutical packaging and medical components manufacturing.

Rising demand for medical plastics in pharmaceutical packaging applications and the rapid growth of the pharmaceutical industry in Mexico and Canada are expected to drive the medical plastics market in the region. For instance, the elimination of stringent regulations by the Mexican government, which had earlier restricted the establishment of new manufacturing units, has resulted in the establishment of new pharmaceutical manufacturing facilities for major companies such as Takeda and Astellas in Mexico.

Product Insights

The Poyphenylsulfone (PPSU) resin segment dominated the medical plastics market with a revenue share of above 51.0% in 2023. The heat and chemical resistance of PPSU can be attributed to this dominance. These plastics possess high strength and durability, making essential surgical tools. These are preferred in surgical robots and biopharmaceutical processing. Polyphenylsulfone exhibits good heat and chemical resistance, making it ideal for metal replacement in medical applications. These plastics possess high flexural strength, impact resistance, and durability and are ideal for producing single- and multi-use surgical instruments. Its high-temperature resistance makes it suitable for multi-use medical devices that are repeatedly steam-sterilized.

Browse through Grand View Research's Plastics, Polymers & Resins Industry Research Reports.

• The global polybutadiene market size was valued at USD 1.88 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2030.

• The global polycarbonate sheet market size was valued at USD 4.64 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2030. 

Key Companies & Market Share Insights

Some key market players include BASF SE; Celanese Corporation; Evonik Industries AG; SABIC; Dow, Inc.; Solvay S.A.; Trinseo S.A.; and Eastman Chemical Company.

• In November 2022, Celanese Corporation announced the acquisition of DuPont's Mobility & Material (M&M) business for USD 11 billion. This strategic move enables Celanese to expand its global reach and enhance its offerings in the environmental sector, particularly in sustainable transportation.

Key Medical Plastics Companies:

The following are the leading companies in the medical plastics market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these medical plastics companies are analyzed to map the supply network.

• Röchling SE & Co. KG

• Nolato AB

• Saint-Gobain

• SABIC

• Orthoplastics Ltd

• Eastman Chemical Company

• Celanese Corporation

• Dow, Inc.

• Tekni-Plex, Inc.

• Solvay S.A.

• HMC Polymers Company Limited

• ARAN BIOMEDICAL TEORANTA

• Trelleborg Group

• Avantor, Inc.

• Trinseo

• Evonik Industries AG

Medical Plastic Market Segmentation

Grand View Research has segmented the global medical plastic market based on product, application, and region:

Medical Plastics Product Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)

• Polyethylene (PE)

• Polypropylene (PP)

• Polycarbonate (PC)

• Liquid Crystal Polymer (LCP)

• Polyphenylsulfone (PPSU)

• Polyethersulfone (PES)

• Polyethylenimine (PEI)

• Polymethyl Methacrylate (PMMA)

• Others

Medical Plastics Process Technology Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Extrusion

• Injection Molding

• Blow Molding

• Other

Medical Plastics Application Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)

• Medical Device Packaging

• Medical Components

• Orthopedic Implant Packaging

• Orthopedic Soft Goods

• Wound Care

• Cleanroom Supplies

• BioPharm Devices

• Mobility Aids

• Sterilization and Infection Prevention

• Tooth Implants

• Denture Base Material

• Other Implants

• Others

Medical Plastics Region Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o U.K.

o France

o Italy

o Netherland

• Asia Pacific

o China

o India

o Japan

• Central & South America

o Brazil

o Argentina

• Middle East & Africa

o Saudi Arabia

o UAE

Order a free sample PDF of the Medical Plastics Market Intelligence Study, published by Grand View Research.

Recent Developments

Some key players operating in market include BASF SE; Celanese Corporation; Evonik Industries AG; SABIC; Dow, Inc.; Solvay S.A.; Trinseo S.A.; Eastman Chemical Company among others.

• In February 2023, Cleanse Corporation announced the acquisition of DUPONT's mobility and mobility business for USD 11.00 billion. This strategic move enables Cleanse to expand its global reach and enhance its offerings in the environmental sector, particularly in sustainable transportation.

• In June 2023, SABIC acquired Clariant's 50% stake in Scientific Design, a renowned catalysis leader. This acquisition bolstered the non-cyclical, technology-driven business and brought it closer to becoming a leading global specialist.

[health-views-updates]

Cosmeceuticals Market 2024 Share, Trend and Segmentation Forecast 2032

The global Medical Imaging Devices Market Revenue is poised for substantial growth in the coming years, according to the latest report by SNS Insider. With the market projected to experience significant expansion, advancements in imaging technology, coupled with increasing prevalence of chronic diseases, are creating a favorable environment for the adoption of cutting-edge medical imaging devices. This growth trajectory reflects the crucial role these technologies play in diagnostics, treatment planning, and improving overall patient care.

Recent innovations in the medical imaging sector, including the adoption of artificial intelligence (AI), machine learning, and data-driven solutions, have transformed how healthcare professionals assess, diagnose, and monitor health conditions. These innovations not only enhance the accuracy of medical diagnoses but also improve workflow efficiency in healthcare settings. Key devices such as MRI machines, CT scanners, ultrasound, and X-ray systems continue to evolve, enabling higher resolution images, faster processing times, and enhanced safety for patients. These advancements are expected to fuel sustained growth in the medical imaging devices market.

A growing demand for non-invasive diagnostic techniques is also propelling the market forward. The increasing incidence of conditions like cancer, cardiovascular diseases, and orthopedic disorders has led to a heightened need for advanced imaging solutions. With an expanding global elderly population, the demand for diagnostic imaging continues to rise, as age-related health issues become more prevalent. In addition to serving diagnostic needs, the capabilities of medical imaging devices are broadening to facilitate precision medicine and minimally invasive procedures, further underscoring their value within modern healthcare.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/2989

Market Drivers and Challenges

The medical imaging devices market is witnessing unprecedented growth opportunities, thanks to supportive government policies, increased healthcare spending, and a surge in hospital and diagnostic center infrastructure. In many developing countries, governments are making strategic investments to enhance their healthcare capabilities, enabling greater access to high-quality imaging services. The establishment of public-private partnerships to bridge healthcare gaps has further boosted the accessibility of advanced diagnostic technologies.

However, the market is not without its challenges. High costs associated with advanced imaging devices and the need for skilled professionals to operate and interpret these devices pose barriers to widespread adoption, especially in low-income regions. Regulatory and compliance considerations, such as FDA approvals and radiation safety standards, also impact the pace of market expansion. Nevertheless, manufacturers are increasingly focusing on affordable, scalable solutions and training programs to address these challenges, which are anticipated to fuel further market penetration.

Key Market Segments and Growth Prospects

The report by SNS Insider categorizes the medical imaging devices market by product type, technology, end-user, and geography, providing a comprehensive analysis of growth prospects within each segment. Among product types, MRI and CT scanners are expected to witness substantial demand due to their versatility and effectiveness in diagnosing complex medical conditions. Additionally, advancements in ultrasound technology and the increasing adoption of hybrid imaging systems in oncology and cardiology are driving the market forward.

The Asia-Pacific region, led by countries like China, India, and Japan, is projected to experience the fastest growth rate due to rapid healthcare infrastructure development, increased healthcare spending, and an aging population. North America, particularly the United States, remains a dominant market due to its well-established healthcare facilities, a high prevalence of chronic diseases, and an ongoing push toward value-based healthcare.

Technological Innovations and Future Outlook

The future of medical imaging devices lies in continued innovation, as companies leverage AI and data analytics to enhance imaging capabilities and outcomes. AI-driven solutions are transforming imaging interpretation, enabling faster and more accurate diagnostics by analyzing large volumes of data in real time. Furthermore, AI algorithms are being integrated into imaging platforms to assist radiologists in identifying abnormalities, reducing human error, and supporting personalized patient care.

Looking ahead, cloud-based solutions and tele-imaging are anticipated to play a pivotal role in improving accessibility to diagnostic imaging in remote and underserved areas. As telehealth services expand globally, cloud-based imaging platforms are enabling radiologists to interpret images from any location, facilitating timely and efficient diagnosis. With the integration of these advanced solutions, the medical imaging devices market is well-positioned for sustained growth and innovation.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[heathcareforallworld]

Global Neck Pain Treatment Solutions Market: Growth and Forecast to 2032

The neck pain treatment solutions market has experienced significant growth in recent years due to the increasing prevalence of neck pain among people of all age groups. Factors such as sedentary lifestyles, the rising aging population, and growing awareness about various treatment options have spurred demand in this sector. As we look ahead to 2032, the market is expected to witness further expansion, driven by advancements in medical technology and a heightened focus on patient comfort and treatment efficiency.

Market Overview

Neck pain is one of the most common musculoskeletal conditions affecting millions of people globally. It can result from various factors, including poor posture, injuries, stress, and degenerative diseases like arthritis. Consequently, the need for effective treatment solutions is critical, leading to the rapid growth of the neck pain treatment solutions market. The demand for non-invasive treatments, pain relief devices, chiropractic care, physical therapy, and minimally invasive surgeries has been rising, pushing market players to invest in new technologies and treatment methodologies.

Key Drivers of Market Growth

Sedentary Lifestyles and Work Culture: Modern lifestyles, characterized by long hours of sitting and poor posture, are one of the key contributors to the rising cases of neck pain. With more people working from home or engaging in desk jobs, neck strain and discomfort have become increasingly common. This shift has heightened the demand for various neck pain treatment options, including ergonomic products, physical therapy, and non-invasive treatments.

Aging Population: The global aging population is another major factor driving market growth. As people age, the likelihood of developing musculoskeletal issues, including neck pain, increases. The elderly are more susceptible to conditions like arthritis, cervical spondylosis, and disc degeneration, which often require ongoing treatment. This demographic is expected to boost the demand for neck pain solutions such as pain management therapies, surgery, and assistive devices.

Technological Advancements: Innovations in medical technology have brought about a wide range of effective neck pain treatment options. New devices and therapies, such as laser treatments, electrotherapy, and wearable pain management devices, have emerged to provide faster relief with fewer side effects. Additionally, advancements in diagnostic tools like MRI and CT scans have improved the accuracy of diagnosing neck pain causes, allowing for more precise treatment plans.

Market Segmentation

The neck pain treatment solutions market can be broadly segmented based on treatment type, end-user, and region.

By Treatment Type: The market is segmented into non-invasive treatments, pharmacological treatments, surgical treatments, and alternative therapies like acupuncture and chiropractic care. Non-invasive treatments, such as physiotherapy, spinal adjustments, and therapeutic massages, are seeing the highest demand due to patient preference for less invasive options.

By End-User: This includes hospitals, clinics, home healthcare, and rehabilitation centers. Hospitals and clinics dominate the market due to the need for professional medical attention and advanced treatment options. However, home healthcare solutions, including wearable devices, are gaining popularity as patients seek convenient treatment methods.

By Region: North America holds a significant market share, largely due to the high prevalence of neck pain, advanced healthcare infrastructure, and awareness of treatment options. Europe and the Asia-Pacific regions are also witnessing significant growth, with increased healthcare expenditure, rising cases of neck pain, and a focus on improving the quality of care.

Industry Challenges

Despite the market's promising growth, certain challenges persist. One key challenge is the high cost of advanced treatment options, particularly for surgical and specialized therapies. Furthermore, limited awareness about certain non-invasive treatments in developing regions may restrict market growth. However, growing initiatives to educate patients and healthcare providers about neck pain management techniques may alleviate these concerns.

Future Outlook and Forecast

Neck Pain Treatment Solutions Market Size was estimated at 23.82 (USD Billion) in 2023. The Neck Pain Treatment Solutions Market Industry is expected to grow from 24.46(USD Billion) in 2024 to 30.3 (USD Billion) by 2032. The Neck Pain Treatment Solutions Market CAGR (growth rate) is expected to be around 2.71% during the forecast period (2025 - 2032).As technological advancements continue and awareness of effective treatments grows, the demand for neck pain solutions will rise. The expansion of telemedicine and at-home treatment devices is also expected to contribute to this growth, making treatments more accessible to patients worldwide.

Conclusion

The neck pain treatment solutions market is poised for considerable expansion in the coming decade. With the increasing incidence of neck pain due to lifestyle factors and aging, coupled with the introduction of innovative treatment technologies, the market offers significant opportunities for healthcare providers and industry players. By addressing the current challenges and tapping into emerging trends, the industry is well-positioned to meet the growing global demand for effective neck pain treatments.

[marketresearchintent]

Image-guided Radiation Therapy (IGRT) Market Analysis: From USD 1.7 Billion in 2023 to USD 2.4 Billion by 2030

The Image-Guided Radiation Therapy (IGRT) market is poised for significant growth, with projections indicating an increase from USD 1.7 billion in 2023 to USD 2.4 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.3% during this period. This growth is driven by advancements in imaging technologies, rising cancer incidence, and an increasing preference for non-invasive treatment options in oncology.

Understanding IGRT

Image-Guided Radiation Therapy is a sophisticated approach that utilizes advanced imaging techniques to enhance the precision of radiation therapy. By incorporating real-time imaging, IGRT allows clinicians to accurately target tumors while minimizing exposure to surrounding healthy tissues. This is particularly crucial in treating cancers that are located near vital organs or structures.

Access Full Report @ https://intentmarketresearch.com/latest-reports/image-guided-radiation-therapy-market-3030.html 

Key Components of IGRT

4D Gating/4D RT: This technique accounts for tumor motion due to respiration, allowing for more accurate targeting.

CT Scanning: Provides detailed cross-sectional images of the body, aiding in precise tumor localization.

LINAC (Linear Accelerator): A device that delivers high-energy radiation to the tumor.

PET/MRI-Guided Radiation Therapy: Combines metabolic imaging with anatomical imaging to improve treatment planning and monitoring.

Portal Imaging: Used for verification of patient positioning before treatment.

Market Dynamics

Drivers of Growth

Rising Cancer Incidence: The global burden of cancer continues to escalate, necessitating more effective treatment modalities. According to the World Health Organization (WHO), cancer cases are expected to rise significantly in the coming years, driving demand for advanced treatment options like IGRT.

Technological Advancements: Continuous innovations in imaging and radiation delivery systems enhance the effectiveness and safety of IGRT. The integration of technologies such as MRI and PET scans into radiation therapy protocols has proven beneficial in improving patient outcomes.

Preference for Non-Invasive Procedures: Patients increasingly prefer non-invasive treatments that offer fewer side effects and quicker recovery times. IGRT aligns with this trend by providing targeted therapy with minimal damage to surrounding tissues.

Healthcare Expenditure Growth: Increased healthcare spending, particularly in emerging economies, facilitates the adoption of advanced medical technologies, including IGRT systems.

Challenges Facing the Market

Despite its promising growth trajectory, the IGRT market faces several challenges:

High Costs: The initial investment required for IGRT systems can be substantial, limiting accessibility for smaller healthcare facilities.

Training and Expertise Requirements: Effective implementation of IGRT requires specialized training for healthcare professionals, which can be a barrier in some regions.

Regulatory Hurdles: Navigating the complex regulatory landscape can delay the introduction of new technologies and therapies.

Competitive Landscape

The IGRT market is characterized by a mix of established players and emerging companies striving to innovate and capture market share. Major companies operating in this space include:

◘ Accuray ◘ Canon ◘ C-Rad ◘ Elekta ◘ GE Healthcare ◘ GenesisCare ◘ Mevion ◘ Philips ◘ RefleXion ◘ Siemens ◘ Sun Nuclear ◘ ViewRay

Download Sample Report @ https://intentmarketresearch.com/request-sample/image-guided-radiation-therapy-market-3030.html

Regional Insights

North America

North America currently dominates the IGRT market due to its advanced healthcare infrastructure, high levels of research funding, and a strong emphasis on cancer treatment innovations. The United States alone accounted for a significant portion of the market share in 2023.

Europe

Europe is also witnessing substantial growth in the IGRT sector, driven by increasing cancer awareness campaigns and government initiatives aimed at improving cancer care services.

Asia-Pacific

The Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period. Factors contributing to this growth include rising healthcare expenditures, increasing prevalence of cancer, and expanding access to advanced medical technologies.

Future Outlook

The future of the IGRT market appears bright as advancements continue to evolve in imaging technologies and radiation delivery systems. Key trends that may shape the market include:

Integration with Artificial Intelligence (AI): AI can enhance image analysis and treatment planning processes, leading to improved patient outcomes.

Expansion into Emerging Markets: As healthcare infrastructure improves in developing countries, there will be increased opportunities for IGRT adoption.

Focus on Personalized Medicine: Tailoring treatments based on individual patient needs will become more prevalent, further driving demand for advanced radiation therapies like IGRT.

Conclusion

The Image-Guided Radiation Therapy market is on a robust growth trajectory fueled by technological advancements, increasing cancer incidence, and a shift towards non-invasive treatments. With an expected rise from USD 1.7 billion in 2023 to USD 2.4 billion by 2030 at a CAGR of 5.3%, stakeholders across the healthcare spectrum must prepare for an evolving landscape that emphasizes precision medicine and improved patient outcomes through innovative treatment modalities like IGRT. As barriers such as cost and training are addressed, the potential for widespread adoption will enhance cancer care globally.

About Us

Intent Market Research (IMR) is dedicated to delivering distinctive market insights, focusing on the sustainable and inclusive growth of our clients. We provide in-depth market research reports and consulting services, empowering businesses to make informed, data-driven decisions.

Our market intelligence reports are grounded in factual and relevant insights across various industries, including chemicals & materials, healthcare, food & beverage, automotive & transportation, energy & power, packaging, industrial equipment, building & construction, aerospace & defense, and semiconductor & electronics, among others.

We adopt a highly collaborative approach, partnering closely with clients to drive transformative changes that benefit all stakeholders. With a strong commitment to innovation, we aim to help businesses expand, build sustainable advantages, and create meaningful, positive impacts.

Contact Us

sales@intentmarketresearch.com

US: +1 463-583-2713